Song, Gwan G <br/><br/>
Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.  [electronic resource] 

 -  The New England journal of medicine  01 2018 
 - 194 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMc1714810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alendronate<br/>Antibodies, Monoclonal<br/>Female<br/>Fractures, Bone<br/>Humans<br/>Osteoporosis